Haselmeier

Haselmeier designs, develops, and manufactures advanced drug delivery systems, specializing in proprietary self-injection devices for subcutaneous applications. The company’s core offering includes sophisticated pen injection systems, along with various other manual and automatic injectors, providing comprehensive solutions for the pharmaceutical and biotechnology industries. These devices are engineered to facilitate safe and effective self-administration of critical medications, incorporating ergonomic design and user-centric features.

The company was founded in 1920 in Stuttgart, Germany, by Wilhelm Haselmeier, initially focusing on the development and supply of glass syringes and other specialized injection equipment. Wilhelm Haselmeier’s foundational insight centered on improving drug delivery mechanisms, which evolved over a century to pioneering the development of injection pens. This long-standing commitment to innovation positioned the company as a key player in self-injection technology.

Haselmeier’s products serve pharmaceutical and biotechnology companies, whose therapies address a wide range of conditions such as fertility issues, growth disorders, diabetes, osteoporosis, and autoimmune diseases. The company's enduring vision is to create products that enable a convenient and comfortable experience for patients, thereby simplifying complex medical regimens and enhancing adherence through thoughtful device design and integrated patient feedback.